ClinicalTrials.Veeva

Menu

The Rule of Bupivacaine Hydrochloride in Skin Graft Donor Site

M

Minia University

Status and phase

Completed
Phase 2

Conditions

Pain Management
Skin Graft Complications

Treatments

Drug: Bupivacain

Study type

Interventional

Funder types

Other

Identifiers

NCT06766474
bupivacaine analgesia

Details and patient eligibility

About

Split Thickness Skin Graft is frequently utilized for reconstructing skin loss of various causes. Unfortunately, the donor site of the STSG has an unavoidable, annoying post-operative pain

Full description

The primary objective of this study was to compare the efficacy of bupivacaine hydrochloride-soaked dressing versus bupivacaine HCL subcutaneous infiltration for postoperative donor site pain control for patients undergoing STSG procedures. The patients were divided in 3 equal groups, investigated soaked dressing vs subcutaneous infiltration vs conventional dressing .

Enrollment

90 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists Physical Status classification I-II
  • scheduled for STSG harvested from a single thigh donor site to reconstruct skin loss post burn or trauma

Exclusion criteria

  • uncooperative
  • refusing patient,
  • under immunosuppressive treatment
  • diabetics
  • lower-limb neuropathy
  • under corticosteroids treatment
  • allergy to the study drug,
  • STSG procedures performed under spinal anesthesia
  • pregnancy
  • had a history of opioid abuse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 3 patient groups

Group I (soaked dressing group)
Experimental group
Description:
the donor site dressing was kept soaked in an aqueous solution of bupivacaine HCL in a concentration of 0.25%.
Treatment:
Drug: Bupivacain
Group II (subcutaneous infiltration group)
Experimental group
Description:
Subcutaneous infiltration of the study medication.
Treatment:
Drug: Bupivacain
Group III (control group)
No Intervention group
Description:
the conventional dressing was applied without any adjectives

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems